Patient Assistance Programs: How They Work and Why They Matter
For many patients, starting a new treatment is only part of the journey. Staying on that therapy can be just as difficult. High health care costs, gaps in insurance coverage,
For many patients, starting a new treatment is only part of the journey. Staying on that therapy can be just as difficult. High health care costs, gaps in insurance coverage,
A Patient Relationship Management platform, often shortened to PRM, is the operational system that organizes patient support program work from first contact through ongoing engagement. In practice, PRM platforms unify
Why device support and concierge services are suddenly a board-level topic Commercial patient support programs used to be defined mainly by reimbursement workflows. That is still true, but the center
The commercialization of specialty medications has transformed the pharmaceutical industry. Many of today’s therapies—particularly those used to treat rare diseases, cancer, or complex chronic conditions—require extensive coordination between healthcare providers,
Advancing Patient Access, Affordability, and High-Touch Support ACCESS USA 2026 arrives at a pivotal moment for U.S. market access and patient support. New affordability dynamics, evolving reimbursement and policy requirements,
In today’s complex pharmaceutical landscape, patient support programs have become integral to successful product commercialization. These programs serve as a bridge between pharma companies, healthcare providers, and patients – helping
My mom taught me all the most important things I know. Things like the importance of family, how to show up for the ones we love, and, of course, the
Designing support programs for patients in rare conditions is a complex endeavor. The traditional approaches that work in high‑volume disease areas often fail when applied to orphan settings. Low patient
In today’s fast-paced pharmaceutical market, commercial leaders are under pressure to deliver more personalized patient support while demonstrating clear value. Patient services are evolving from a back-end support role to
Advances in pharmaceuticals have little impact if patients don’t stick with their treatment. Medication non-adherence is a widespread problem – in fact, studies show that on average only about 50%